TaySachs
Tay-Sachs disease is a rare inherited neurodegenerative disorder caused by mutations in the HEXA gene, which lead to a deficiency of the enzyme beta-hexosaminidase A. This enzymatic defect prevents the breakdown of GM2 ganglioside within lysosomes, resulting in GM2 accumulation in neurons and progressive neural damage. The condition is part of a broader group known as GM2 gangliosidoses.
Tay-Sachs is inherited in an autosomal recessive pattern. Carrier frequency is notably higher in certain populations,
The most common form is the infantile variant, with onset typically between 3 and 6 months of
Diagnosis is based on measuring beta-hexosaminidase A activity in blood or leukocytes; a deficient activity suggests
There is no cure for Tay-Sachs disease. Management is supportive and multidisciplinary, focusing on symptom relief